Skin Barrier Function Assessment in Rare Diseases Caused by Abnormal Sterol and Isoprenoid Metabolism: A Pilot Study
The purpose of this study is to determine the differences in the skin barrier function of subjects with SLS or SLOS versus subjects with normal skin.
Smith-Lemli-Opitz syndrome, Sjögren-Larsson syndrome, control group with normal skin
You must have a confirmed diagnosis of SLOS or SLS. Subjects not affected by skin barrier disorders and be at least six months old
6 - 100
Healthy Volunteers Needed
Duration of Participation
One 3 hour visit